Gedeon Richter, Egis, and Meditop — plan to establish contract manufacturing and localization of medicine production in Uzbekistan, according to the Director of the Pharmaceutical Industry Development ...

“BRI has been found to be superior in estimating risk for clinical endpoints including cardiometabolic disease, kidney ...